Order results by:
Issue | Title | |
Vol 5, No 2 (2012) | THE ANALYSIS OF COST OF ILLNESS OF PREGNANT WOMEN WITH SYPHILIS | Abstract similar documents |
A. I. Ovod, M. D. Mukovnina | ||
"... treatment of pregnant women with syphilis, and also members of their families is carried out ..." | ||
Vol 7, No 2 (2014) | THE ANALYSIS OF THE EFFECTIVENESS OF THROMBOPROPHYLAXIS AMONG PREGNANT WOMEN WITH MESENCHYMAL DYSPLASIA | Abstract similar documents |
E. G. Kudinova, A. P. Momot, N. V. Trukhacheva | ||
"... the analysis of the effectiveness of thromboprophylaxis among pregnant women with mesenchymal ..." | ||
Vol 7, No 2 (2014) | MANAGEMENT OF MAGNESIUM DEFICIENCY IN PREGNANT WOMEN: PHARMACOEPIDEMIOLOGIC STUDY | Abstract similar documents |
D. V. Blinov, U. V. Zimovina, E. M. Dzhobava | ||
"... in the general population, particularly among pregnant women have been previously conducted in Russia. Objectives ..." | ||
Vol 10, No 2 (2017) | PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY | Abstract similar documents |
A. V. Rudakova, S. A. Protsenko, I. A. Koroleva | ||
"... drugs and the expenses for their administration were taken into account. In the sensitivity analysis ..." | ||
Vol 5, No 1 (2012) | DYNAMICS OF PREFERENTIAL MAINTENANCE OF CITIZENS WITH ANTIHYPERTENSIVE DRUGS AT THE EXPENSE OF THE REGIONAL BUDGET | Abstract similar documents |
I. I. Lavrentyeva, A. I. Khokhlov, I. N. Kagramanyan, T. A. Gorokhova | ||
"... of an arterial hypertension at the expense of the regional budget for 2008-2011 has revealed expansion ..." | ||
Vol 9, No 2 (2016) | EVALUATION OF RATIONALITY OF EXPENSES ON TREATMENT OF SEVERE COMMUNITY-ACQUIRES PNEUMONIA IN MULTI-PROFILE HOSPITAL | Abstract similar documents |
I. V. Demko, N. V. Gordeeva, E. N. Bochanova, N. I. Golovina, A. Yu. Kraposhina, I. A. Soloveva, E. A. Sobko, T. V. Gaygolnik, S. V. Chubarova | ||
"... Purpose — to study rationality of financial expenses on the treatment of patients with the severe ..." | ||
Vol 7, No 3 (2014) | ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION | Abstract similar documents |
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
"... of the patients with OD and to optimize state expenses for this group of patients it is necessary to approve ..." | ||
Vol 7, No 4 (2014) | ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS | Abstract similar documents |
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva | ||
"... supply at the expense of funds of the healthcare system of the Russian Federation. Study methodology ..." | ||
Vol 8, No 4 (2015) | PLANNING OF EXTENT AND FINANCIAL EXPENSES FOR DELIVERY OF HEALTH CARE IN HOSPITALS AT THE FEDERAL AND REGIONAL LEVELS | Abstract similar documents |
M. V. Sura | ||
"... Introduction. Extent and financial expenses for the delivery of health care in hospitals ..." | ||
Vol 13, No 2 (2020) | Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation | Abstract similar documents |
S. V. Malchikova, A. N. Korobeinikova, N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva | ||
Vol 10, No 2 (2017) | CLINICAL AND ECONOMIC EVALUATION OF CHRONIC DISEASE TREATMENT: A DISCREPANCY BETWEEN THE TRADITIONAL PHARMACOECONOMIC AND SOCIO-ECONOMIC ANALYSES | Abstract similar documents |
O. V. Zhukova, S. V. Kononova | ||
Vol 11, No 4 (2018) | “Near miss” in obstetrics: classification, evaluation, and significance for healthcare technology assessment | Abstract similar documents |
I. K. Мamontova, T. V. Shevlyakovа, E. I. Petrova | ||
"... a potential threat to pregnant women. To characterize such states, the definition was introduced – “maternal ..." | ||
Vol 13, No 1 (2020) | Health technology assessment in obstetrics: advantage of tailored conservative strategy vs surgical therapies of monochorionic twin complicated by TRAP-sequence | Abstract similar documents |
V. I. Tsibizova, I. E. Govorov, I. I. Averkin, N. M. Khamani, D. V. Blinov | ||
"... to dynamically monitor the condition of a pregnant and healthy fetus and to prolong pregnancy without surgery ..." | ||
Vol 11, No 2 (2018) | Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations | Abstract similar documents |
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov | ||
"... ) in 2018 provides for the reimbursement for hospital stay expenses by the compulsory medical insurance fund ..." | ||
Vol 9, No 4 (2016) | COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY | Abstract similar documents |
V. S. Dombrovskiy, G. R. Khachatryan | ||
"... activities in the United States, Canada, the Netherlands and Germany for adult non-pregnant population ..." | ||
Vol 8, No 3 (2015) | ORGANIZATION AND ANALYSIS OF THE COMMISSION'S WORK ON THE SELECTION AND REFERRAL OF PATIENTS IN A MEDICAL INSTITUTION FOR TREATMENT USING ASSISTED REPRODUCTIVE TECHNOLOGIES ON THE TERRITORY OF THE CHELYABINSK REGION | Abstract similar documents |
M. G. Moskvicheva, V. V. Saharova, Yu. A. Semenov, E. V. Orehova | ||
"... at the expense of means of regional and federal budgets. In the work the Commission considers indications ..." | ||
Vol 10, No 4 (2017) | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET | Abstract similar documents |
V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva | ||
"... Federation restricts the availability of highly effective innovative drugs and leads to unnecessary expenses ..." | ||
Vol 10, No 4 (2017) | PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION | Abstract similar documents |
M. Yu. Frolov, V. A. Rogov | ||
"... expenses, and also implies a reshuffle of the expenses between different items. For example, increasing ..." | ||
Vol 10, No 3 (2017) | Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients | Abstract similar documents |
N. K. Mazina, P. V. Mazin | ||
"... with increasing expenses and thus impacts the healthcare budgets at various levels. The aim was to study ..." | ||
Vol 5, No 1 (2012) | COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS | Abstract similar documents |
R. I. Yagudina, I. Yu. Zinchuk, M. M. Litvinenko | ||
"... consists in calculation of the expenses connected any given disease, without notice of effectiveness ..." | ||
Vol 5, No 2 (2012) | WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM | Abstract similar documents |
A. I. Borodin | ||
"... and with critical level is developed. Efficiency is received at the expense of economy of operating assets ..." | ||
Vol 10, No 3 (2017) | Evaluation of economic damage from multiple sclerosis in the city of Ufa, Russia | Abstract similar documents |
E. V. Ivanova, K. Z. Bachtiyarova | ||
"... ) expenses leads to a sharp increase in indirect costs; this situation necessitates an updated assessment ..." | ||
Vol 6, No 4 (2013) | Pharmacoeconomic study of nutrition support in the conditions of current health care system in Russia | Abstract similar documents |
I. A. Metelkin, R. I. Yagudina | ||
"... costs were taken into account: expenses for drug therapy, hospitalization (intensive care unit ..." | ||
Vol 11, No 3 (2018) | Use of medications in children hospitalized with community-acquired pneumonia | Abstract similar documents |
D. D. Siukaeva, I. A. Narkevich, V. N. Timchenko, O. D. Nemyatyh, N. A. Maslova | ||
"... .54%); their cost took 77.22% of the expenses and covered 48.97% of the drug list. ..." | ||
Vol 12, No 1 (2019) | Individual cost accounting in the management of medical organizations | Abstract similar documents |
I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali | ||
"... expenses. Implementation of this approach is expected to increase the work efficiency in most medical ..." | ||
Vol 6, No 4 (2013) | Фармакоэкономический анализ использования лираглутида в составе комбинированной терапии в лечении сахарного диабета 2-го типа | Abstract similar documents |
A. Yu. Kulikov, I. V. Novikov | ||
"... in for patients with type 2 diabetes in condition of the Russian health care system. Total medical expenses ..." | ||
Vol 8, No 2 (2015) | CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA | Abstract similar documents |
Elena Albertovna Sobko, Natalya Vladimirovna Gordeeva, Angelina Yurievna Kraposhina, Irina Anatolyevna Soloveva, Svetlana Vladimirovna Chubarova, Olga Petrovna Ishenko, Irina Vladimirovna Demko, Maria Michailovna Loktionova | ||
"... allergic bronchial asthma, and is able tto reduce financial expenses considerably. ..." | ||
Vol 8, No 2 (2015) | ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA | Abstract similar documents |
Elamin H. Elbasha, Elena Aleksandrovna Pyadushkina, Maria Vladimirovna Avxentyeva, Alexander Gennadievich Tolkushin, Maxim Yurievich Frolov | ||
"... as it had clinical benefits with affordable additional expenses. The increment cost efficiency rate (ICER ..." | ||
Vol 8, No 4 (2015) | CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS | Abstract similar documents |
E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva | ||
"... of application filing for Eltrombopag inclusion to such list, and standards of the financial expenses per medical ..." | ||
Vol 9, No 2 (2016) | PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA | Abstract similar documents |
N. A. Avxentyev, M. Yu. Frolov | ||
"... ,000 rubles less than second best option. The overall healthcare annual expenses of using combined drug are 5 ..." | ||
Vol 10, No 1 (2017) | BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS | Abstract similar documents |
E. A. Pyadushkina | ||
"... , and the regulations of financial expenses in the Russian Federation Health system in 2016, were used in this analysis ..." | ||
Vol 10, No 1 (2017) | PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM | Abstract similar documents |
N. K. Mazina, I. V. Sheshunov, P. V. Мazin, Yu. V. Kislitsin, E. M. Markova | ||
"... . Conclusion. Direct costs modeling was performed to estimate annual expenses (per patient) of the adjunctive ..." | ||
Vol 10, No 3 (2017) | ABC-analysis of pharmacotherapy in children hospitalized with bronchial asthma exacerbations | Abstract similar documents |
O. V. Zhukova, S. V. Kononova | ||
"... ) according to the selected criteria. In the present study, the selection criterion was the amount of expenses ..." | ||
Vol 11, No 3 (2018) | Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus | Abstract similar documents |
A. G. Tolkushin, N. L. Pogudina | ||
"... obtained from the VeD price registry. Medical and nonmedical expenses are calculated on the basis ..." | ||
Vol 12, No 4 (2019) | Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation | Abstract similar documents |
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev | ||
"... / biosimilars, no saving is expected; on the contrary, expenses will increase by 14.1% to 400 million rubles ..." | ||
Vol 9, No 3 (2016) | CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY | Abstract similar documents |
E. A. Pyadushkina, M. Yu. Frolov | ||
"... as the second concomitant drug and reduce the budget expenses for antiseizure therapy by 11.45 and 1.85 million ..." | ||
Vol 13, No 3 (2020) | The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups | Abstract similar documents |
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan | ||
"... 's disease and ulcerative colitis. Materials and methods. The expenses on GEBD and SI for one case ..." | ||
1 - 37 of 37 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)